DAWN PETTY: Open Payments
NPI 1134404957 · LEE'S SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 14 payments from 10 companies in 2025. Trend: 2023 $1,036 · 2024 $848 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $82 |
| Amgen Inc. | 3 | $47 |
| UCB, Inc. | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $32 |
| Grifols USA, LLC | 1 | $29 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| GENZYME CORPORATION | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: RINVOQ, Bimzelx, TREMFYA, Gamunex-C, SKYRIZI, ZTLido, COSENTYX, BENLYSTA.
Industry payments across MO — which companies pay providers there.
